Small Call to Action Headline

  Menu                          GG Advisors

CUSTOM JAVASCRIPT / HTML

Building Value for Companies And Organizations for Over Thirty Years















 
    Building Value for Companies
    and Organizations for over 
    30 Years



   

Navigate the Transition Back to Work, School, and More With Our COVID-19 Defense Products

GG Advisors has teamed with leading U.S. and European Manufacturers for immediate shipment of FDA 510K Certified Medical Grade Nitrile Gloves, Gowns, Hand Sanitizer, COVID-19 Safety Certified Protective Masks, and Rapid Point-of-care or Whole Blood tests. We can help you get the healthcare equipment your organization needs to stay safe and healthy.

FDA EUA Approval For US Use, Call For Status

MOQ: 10,000 Tests 
Results in 10 Minutes, No Lab Equipment Required

This test is for detection of SARS-Covid19  nucleocapsid protein antigen. Antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Rapid diagnosis of SARS-CoV-2 infection will help healthcare professionals to treat patients and control the disease more efficiently and effectively.
Materials include
  ● 20 Test Cassettes
  ● 20 Sterile Swabs
  ● 20 Extraction Tubes and Droppers
  ● 1 Workstation
  ● 2 Buffers
  ● 1 Package Insert

MOQ: 1 M Boxes

We have established partnerships with over 27 glove manufacturers in Asia and have a logistics company that specializes in Quality Standards Implementation, Supply Chain Management, and Performance Enhancement Consulting, ensuring that the products reach your location in a timely manner. FDA 510K/CE/EN455/EN374/ISO approved. Requirements: PO & Verifiable BCL/POF shared A2A. This gets the order moving at rapid pace.

GGA Brand of Choice- Cranberry

Cranberry Evolve (300 gloves/box)

Cranberry Contour Plus+ (100 gloves/box)

MOQ: 10,000 Tests 
Emergency Use Authorized (EUA)

● Can Handle Mass Orders
● Time to Results: 10 Minutes
● Clinical Evaluation: Positive Percent Agreement (PPA): IgG 96.7%; IgM 86.7%; Overall 96.7%. Negative Percent Agreement (NPA): IgG 98.0%; IgM 99.0%; Overall 97.0%
● ​Clinical Agreement with Characterized Samples: Sensitivity: IgG 96.7%; IgM 100%; Combined 100%​, Specificity: IgG 97.5%; IgM 100%; Combined 97.5%​
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem dolore, alias, numquam enim ab voluptate id quam harum ducimus cupiditate similique quisquam et deserunt, recusandae.

Small Call to Action Headline